As reported, CD5+ DLBCL is related to an increased serum lactate dehydrogenase level, an advanced Ann Arbor stage, high risk scores of an international prognostic index (IPI), and more frequencies of central nervous system (CNS) relapse (7, 8). Here, CD5 is linked to diffuse large B-cell lymphoma.